Copyright
©The Author(s) 2025.
World J Cardiol. Dec 26, 2025; 17(12): 110450
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.110450
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.110450
Figure 1 Graphical abstract: Patient characteristics and outcomes.
1In orange colour: In the first 5-year recruitment period. 2In blue colour: In the second 5-year recruitment period. ACEI/ARBs: Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers; BB: Beta-blockers; NYHA: New York Heart Association; MI: Myocardial infarction; MR: Mitral valve regurgitation; RCT: Randomized controlled trials.
- Citation: Kaddoura R, Dakhil Z, Al-Badriyeh D, Abushanab D, Rafie I, Al-Hijji M. Temporal trends in characteristics and outcomes of patients undergoing percutaneous mitral valve repair. World J Cardiol 2025; 17(12): 110450
- URL: https://www.wjgnet.com/1949-8462/full/v17/i12/110450.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i12.110450
